Epigenetics is characterized by molecular modifications able to shape gene expression profiles in response to inner and external stimuli. Therefore, epigenetic elements are able to provide intriguing and useful information for the comprehension and management of different human conditions, including aging process, and diseases. On this subject, Age-related Macular Degeneration (AMD) represents one of the most frequent age-related disorders, dramatically affecting the quality of life of older adults worldwide. The etiopathogenesis is characterized by an interplay among multiple genetic and non-genetic factors, which have been extensively studied. Nevertheless, a deeper dissection of molecular machinery associated with risk, onset, progression and effectiveness of therapies is still missing. In this regard, epigenetic signals may be further explored to disentangle disease etiopathogenesis, the possible therapeutic avenues and the differential response to AMD treatment. This review will discuss the epigenomic signatures mostly investigated in AMD, which could be applied to improve the knowledge of disease mechanisms and to set-up novel or modified treatment options.
GuptaRAhnRLaiK, et al. Landscape of long noncoding RNAs in psoriatic and healthy skin. J Invest Dermatol2016; 136: 603–609.
2.
ZentnerGEHenikoffS.Regulation of nucleosome dynamics by histone modifications. Nat Struct Mol Biol2013; 20: 259–266.
3.
FurrowREChristiansenFBFeldmanMW.Environment-sensitive epigenetics and the heritability of complex diseases. Genetics2011; 189: 1377–1387.
4.
PenningtonKLDeAngelisMM.Epigenetic mechanisms of the aging human retina. J Exp Neurosci2015; 9: 51–79.
5.
LigthartSMarziCAslibekyanS, et al. DNA methylation signatures of chronic low-grade inflammation are associated with complex diseases. Genome Biol2016; 17: 255.
6.
LecamwasamAEkinciEISafferyR, et al. Potential for novel biomarkers in diabetes-associated chronic kidney disease: epigenome, metabolome, and gut microbiome. Biomedicines2020; 8(9): 341.
7.
OnwukaJULiDLiuY, et al. A panel of DNA methylation signature from peripheral blood may predict colorectal cancer susceptibility. BMC Cancer2020; 20: 692.
8.
GuoDLvJChenX, et al. Study of miRNA interactome in active rheumatoid arthritis patients reveals key pathogenic roles of dysbiosis in the infection-immune network. Rheumatology (Oxford)2021; 60(3): 1512–1522.
9.
CascellaRStrafellaCCaputoV, et al. Towards the application of precision medicine in age-related macular degeneration. Prog Retin Eye Res2018; 63: 132–146.
10.
GBD 2019 Blindness and Vision Impairment Collaborators, Vision Loss Expert Group of the Global Burden of Disease Study. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. Lancet Glob Health2021; 9(2): e144–e160.
11.
RicciFBandelloFNavarraP, et al. Neovascular age-related macular degeneration: therapeutic management and new-upcoming approaches. Int J Mol Sci2020; 21(21): 8242.
12.
GemenetziMLoteryAJ.Epigenetics in age-related macular degeneration: new discoveries and future perspectives. Cell Mol Life Sci2020; 77: 807–818.
13.
PoolFMKielCSerranoL, et al. Repository of proposed pathways and protein-protein interaction networks in age-related macular degeneration. NPJ Aging Mech Dis2020; 6: 2.
14.
CascellaRStrafellaCLongoG, et al. Uncovering genetic and non-genetic biomarkers specific for exudative age-related macular degeneration: significant association of twelve variants. Oncotarget2018; 9: 7812–7821.
15.
FritscheLGIglWBaileyJNC, et al. A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants. Nat Genet2016; 48: 134–143.
16.
CascellaRRagazzoMStrafellaC, et al. Age-related macular degeneration: insights into inflammatory genes. J Ophthalmol2014; 2014: 582842.
17.
ZampattiSRicciFCusumanoA, et al. Review of nutrient actions on age-related macular degeneration. Nutr Res2014; 34: 95–105.
18.
LepreTCascellaRMissiroliF, et al. Polymorphisms in ARMS2 (LOC387715) and LOXL1 genes in the Japanese with age-related macular degeneration. Am J Ophthalmol2011; 152: 325–326; author reply 326.
19.
PengC-HChangY-LKaoC-L, et al. SirT1—a sensor for monitoring self-renewal and aging process in retinal stem cells. Sensors (Basel)2010; 10: 6172–6194.
20.
Miranda FurtadoCLDosSantosLucianoMCSilva SantosRD, et al. Epidrugs: targeting epigenetic marks in cancer treatment. Epigenetics2019; 14: 1164–1176.
21.
LopomoACoppedèF.Pharmacoepigenetics and pharmacoepigenomics of gastrointestinal cancers. Expert Rev Gastroenterol Hepatol2018; 12: 49–62.
22.
Gil-MartínezMSantos-RamosPFernández-RodríguezM, et al. Pharmacological advances in the treatment of age-related macular degeneration. Curr Med Chem2020; 27: 583–598.
23.
LimTHLaiTYYTakahashiK, et al. Comparison of ranibizumab with or without Verteporfin photodynamic therapy for polypoidal choroidal vasculopathy: the EVEREST II randomized clinical trial. JAMA Ophthalmol2020; 138: 935–942.
24.
KimJParkJRChoiJ, et al. Tie2 activation promotes choriocapillary regeneration for alleviating neovascular age-related macular degeneration. Sci Adv2019; 5: eaau6732.
25.
HunterASpechlerPACwangerA, et al. DNA methylation is associated with altered gene expression in AMD. Invest Ophthalmol Vis Sci2012; 53: 2089–2105.
26.
GemenetziMLoteryAJ.The role of epigenetics in age-related macular degeneration. Eye (Lond)2014; 28: 1407–1417.
27.
WeiLLiuBTuoJ, et al. Hypomethylation of the IL17RC promoter associates with age-related macular degeneration. Cell Rep2012; 2: 1151–1158.
28.
OliverVFFranchinaMJaffeAE, et al. Hypomethylation of the IL17RC promoter in peripheral blood leukocytes is not a hallmark of age-related macular degeneration. Cell Rep2013; 5: 1527–1535.
29.
OliverVFJaffeAESongJ, et al. Differential DNA methylation identified in the blood and retina of AMD patients. Epigenetics2015; 10: 698–707.
30.
SobrinLSeddonJM.Nature and nurture- genes and environment- predict onset and progression of macular degeneration. Prog Retin Eye Res2014; 40: 1–15.
31.
PorterLFSaptarshiNFangY, et al. Whole-genome methylation profiling of the retinal pigment epithelium of individuals with age-related macular degeneration reveals differential methylation of the SKI, GTF2H4, and TNXB genes. Clin Epigenetics2019; 11: 6.
32.
GoyalDLimesandSWGoyalR.Epigenetic responses and the developmental origins of health and disease. J Endocrinol2019; 242: T105–T119.
33.
MeigsJBCupplesLAWilsonPW.Parental transmission of type 2 diabetes: the Framingham Offspring Study. Diabetes2000; 49: 2201–2207.
34.
GuilloteauPZabielskiRHammonHM, et al. Adverse effects of nutritional programming during prenatal and early postnatal life, some aspects of regulation and potential prevention and treatments. J Physiol Pharmacol2009; 60(Suppl. 3): 17–35.
35.
ChenAC-HLeeKFYeungWSB, et al. Human embryonic stem cells as an in vitro model for studying developmental origins of type 2 diabetes. World J Stem Cells2020; 12: 761–775.
36.
ZoghbiHYBeaudetAL. Epigenetics and human disease. Cold Spring Harb Perspect Biol2016; 8: a019497.
37.
HorsthemkeB.A critical view on transgenerational epigenetic inheritance in humans. Nat Commun2018; 9: 2973.
38.
GorenjakVVanceDRDadeS, et al. Epigenome-wide association study in healthy individuals identifies significant associations with DNA methylation and PBMC extract VEGF-A concentration. Clin Epigenetics2020; 12: 79.
39.
MartinelliSKanduriMMaffeiR, et al. ANGPT2 promoter methylation is strongly associated with gene expression and prognosis in chronic lymphocytic leukemia. Epigenetics2013; 8: 720–729.
40.
SuuronenTNuutinenTRyhänenT, et al. Epigenetic regulation of clusterin/apolipoprotein J expression in retinal pigment epithelial cells. Biochem Biophys Res Commun2007; 357: 397–401.
41.
FrancisPJ.The influence of genetics on response to treatment with ranibizumab (Lucentis) for age-related macular degeneration: the Lucentis Genotype Study (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc2011; 109: 115–156.
42.
AbediFWickremasingheSRichardsonAJ, et al. Variants in the VEGFA gene and treatment outcome after anti-VEGF treatment for neovascular age-related macular degeneration. Ophthalmology2013; 120: 115–121.
43.
ParmeggianiFCostagliolaCSemeraroF, et al. Effect of factor XIII-A G185T polymorphism on visual prognosis after photodynamic therapy for neovascular macular degeneration. Int J Mol Sci2015; 16: 19796–19811.
44.
MatuškováVBalcarVJKhanNA, et al. CD36 gene is associated with intraocular pressure elevation after intravitreal application of anti-VEGF agents in patients with age-related macular degeneration: implications for the safety of the therapy. Ophthalmic Genet2018; 39: 4–10.
45.
YouQSGaberRMeshiA, et al. High-dose high-frequency aflibercept for recalcitrant neovascular age-related macular degeneration. Retina2018; 38: 1156–1165.
46.
LazzeriSOrlandiPPiaggiP, et al. IL-8 and VEGFR-2 polymorphisms modulate long-term functional response to intravitreal ranibizumab in exudative age-related macular degeneration. Pharmacogenomics2016; 17: 35–39.
47.
LazzeriSFigusMOrlandiP, et al. VEGF-A polymorphisms predict short-term functional response to intravitreal ranibizumab in exudative age-related macular degeneration. Pharmacogenomics2013; 14: 623–630.
48.
GlossopJRNixonNBEmesRD, et al. DNA methylation at diagnosis is associated with response to disease-modifying drugs in early rheumatoid arthritis. Epigenomics2017; 9: 419–428.
49.
SatoKKumagaiNSuzukiN.Alteration of the DNA methylation signature of renal erythropoietin-producing cells governs the sensitivity to drugs targeting the hypoxia-response pathway in kidney disease progression. Front Genet2019; 10: 1134.
50.
LambertNGElShelmaniHSinghMK, et al. Risk factors and biomarkers of age-related macular degeneration. Prog Retin Eye Res2016; 54: 64–102.
51.
LinHQianJCastilloAC, et al. Effect of miR-23 on oxidant-induced injury in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci2011; 52: 6308–6314.
52.
BlasiakJWatalaCTuuminenR, et al. Expression of VEGFA-regulating miRNAs and mortality in wet AMD. J Cell Mol Med2019; 23: 8464–8471.
53.
GrassmannFSchoenbergerPGABrandlC, et al. A circulating microrna profile is associated with late-stage neovascular age-related macular degeneration. PLoS One2014; 9: e107461.
54.
MénardCRezendeFAMiloudiK, et al. MicroRNA signatures in vitreous humour and plasma of patients with exudative AMD. Oncotarget2016; 7: 19171–19184.
55.
ErtekinSYıldırımODinçE, et al. Evaluation of circulating miRNAs in wet age-related macular degeneration. Mol Vis2014; 20: 1057–1066.
56.
LukiwWJSurjyadiptaBDuaP, et al. Common micro RNAs (miRNAs) target complement factor H (CFH) regulation in Alzheimer’s disease (AD) and in age-related macular degeneration (AMD). Int J Biochem Mol Biol2012; 3: 105–116.
57.
ZhangPLuBXuF, et al. Analysis of long noncoding RNAs in choroid neovascularization. Curr Eye Res2020; 45(11): 1403–1414.
58.
ZhangLZengHWangJ-H, et al. Altered long non-coding RNAs involved in immunological regulation and associated with choroidal neovascularization in mice. Int J Med Sci2020; 17: 292–301.
59.
ChenXSunRYangD, et al. LINC00167 regulates RPE differentiation by targeting the miR-203a-3p/SOCS3 axis. Mol Ther Nucleic Acids2020; 19: 1015–1026.
60.
StrafellaCErrichielloVCaputoV, et al. The interplay between miRNA-related variants and age-related macular degeneration: EVIDENCE of association of MIR146A and MIR27A. Int J Mol Sci2019; 20(7): 1578.
61.
GhanbariMErkelandSJXuL, et al. Genetic variants in microRNAs and their binding sites within gene 3’UTRs associate with susceptibility to age-related macular degeneration. Hum Mutat2017; 38: 827–838.
62.
PoppNAYuDGreenB, et al. Functional single nucleotide polymorphism in IL-17A 3’ untranslated region is targeted by miR-4480 in vitro and may be associated with age-related macular degeneration. Environ Mol Mutagen2016; 57: 58–64.
63.
SanGiovanniJPSanGiovanniPMSapiehaP, et al. miRNAs, single nucleotide polymorphisms (SNPs) and age-related macular degeneration (AMD). Clin Chem Lab Med2017; 55: 763–775.
64.
StrafellaCCaputoVTermineA, et al. Genetic determinants highlight the existence of shared etiopathogenetic mechanisms characterizing age-related macular degeneration and neurodegenerative disorders. Frontiers in Neurology. Epub ahead of print 31 May 2021. DOI: 10.3389/fneur.2021.626066.
65.
ReichSJFosnotJKurokiA, et al. Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model. Mol Vis2003; 9: 210–216.
66.
YuA-MTianYTuM-J, et al. MicroRNA pharmacoepigenetics: posttranscriptional regulation mechanisms behind variable drug disposition and strategy to develop more effective therapy. Drug Metab Dispos2016; 44: 308–319.
67.
Corso-DíazXJaegerCChaitankarV, et al. Epigenetic control of gene regulation during development and disease: a view from the retina. Prog Retin Eye Res2018; 65: 1–27.
68.
AndersonKWChenJWangM, et al. Quantification of histone deacetylase isoforms in human frontal cortex, human retina, and mouse brain. PLoS One2015; 10: e0126592.
69.
GolestanehNChuYChengSK, et al. Repressed SIRT1/PGC-1α pathway and mitochondrial disintegration in iPSC-derived RPE disease model of age-related macular degeneration. J Transl Med2016; 14: 344.
70.
MaloneySCAnteckaEGrannerT, et al. Expression of SIRT1 in choroidal neovascular membranes. Retina2013; 33: 862–866.
71.
CrossonCEManiSKHusainS, et al. Inhibition of histone deacetylase protects the retina from ischemic injury. Invest Ophthalmol Vis Sci2010; 51: 3639–3645.
72.
TanitoMMasutaniHKimY-C, et al. Sulforaphane induces thioredoxin through the antioxidant-responsive element and attenuates retinal light damage in mice. Invest Ophthalmol Vis Sci2005; 46: 979–987.
73.
UmlaufDMouradR.The 3D genome: from fundamental principles to disease and cancer. Semin Cell Dev Biol2019; 90: 128–137.
74.
TanLXingDDaleyN, et al. Three-dimensional genome structures of single sensory neurons in mouse visual and olfactory systems. Nat Struct Mol Biol2019; 26: 297–307.
75.
NorrieJLLupoMSXuB, et al. Nucleome dynamics during retinal development. Neuron2019; 104: 512–528.e11.
76.
DiakatouMManesGBocquetB, et al. Genome editing as a treatment for the most prevalent causative genes of autosomal dominant retinitis pigmentosa. Int J Mol Sci2019; 20(10): 2542.
77.
HardingPMoosajeeM.The molecular basis of human anophthalmia and microphthalmia. J Dev Biol2019; 7(3): 16.
78.
WangJZibettiCShangP, et al. ATAC-Seq analysis reveals a widespread decrease of chromatin accessibility in age-related macular degeneration. Nat Commun2018; 9: 1364.
79.
LuuJKallestadLHoangT, et al. Epigenetic hallmarks of age-related macular degeneration are recapitulated in a photosensitive mouse model. Hum Mol Genet2020; 29: 2611–2624.
80.
ZhangJZhouY.Identification of key genes and pathways associated with age-related macular degeneration. J Ophthalmol2020; 2020: 2714746.
81.
StrunzTLauwenSKielC, et al. A transcriptome-wide association study based on 27 tissues identifies 106 genes potentially relevant for disease pathology in age-related macular degeneration. Sci Rep2020; 10: 1584.
82.
CiuculeteDMVoisinSKularL, et al. meQTL and ncRNA functional analyses of 102 GWAS-SNPs associated with depression implicate HACE1 and SHANK2 genes. Clin Epigenetics2020; 12: 99.
83.
LiXHeSZhaoM.An updated review of the epigenetic mechanism underlying the pathogenesis of age-related macular degeneration. Aging Dis2020; 11: 1219–1234.
84.
ZertiDCollinJQueenR, et al. Understanding the complexity of retina and pluripotent stem cell derived retinal organoids with single cell RNA sequencing: current progress, remaining challenges and future prospective. Curr Eye Res2020; 45: 385–396.
85.
CascellaRStocchiLStrafellaC, et al. Comparative analysis between saliva and buccal swabs as source of DNA: lesson from HLA-B*57:01 testing. Pharmacogenomics2015; 16: 1039–1046.
86.
AjanaSCougnard-GrégoireAColijnJM, et al. Predicting progression to advanced age-related macular degeneration from clinical, genetic and lifestyle factors using machine learning. Ophthalmology2021; 128(4): 587–597.
